Structural Heart Devices Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 5.0 billion
Estimated Base Value
2035 Forecast
US$ 8.7 billion
Projected Market Value
CAGR 2026–2035
5.7%
Compound Annual Growth
Largest Segment
Transcatheter Aortic Valve Replacement Devices
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
Asia Pacific
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Terumo Corporation
Emerging Players
Foldax, Cardiovalve
Structural Heart Devices Market Overview
The Structural Heart Devices market covers specialized medical devices for minimally invasive treatment and repair of structural heart diseases. This includes congenital defects, valvular disorders, and other anatomical abnormalities of the heart. The market focuses on percutaneous and transcatheter-based interventions, providing alternatives to traditional open-heart surgery. Devices for valve repair and replacement, septal defect closure, and left atrial appendage occlusion are key components, aiming to improve cardiac function and patient outcomes by addressing structural imperfections within the heart chambers, walls, and valves. Purchasers include hospitals, specialty cardiology clinics, ambulatory surgical centers, and academic and research institutes.
The Structural Heart Devices market is estimated at $5.0 Bn in 2025 and is forecast to reach $8.7 Bn in 2035, growing at a CAGR of 5.7% from 2025 to 2035. Demand is driven by the growing global prevalence of structural heart diseases and an aging population, which increases the patient pool for interventions. Improved diagnostic techniques also contribute to earlier disease detection. However, high device and procedure costs, stringent regulatory processes, and the potential for procedural complications act as restraints on market growth.
The market is segmented by Type (Transcatheter Aortic Valve Replacement Devices, Transcatheter Mitral Valve Repair Devices, Transcatheter Mitral Valve Replacement Devices, Transcatheter Tricuspid Valve Repair & Replacement Devices, Patent Foramen Ovale Closure Devices, Atrial Septal Defect Closure Devices, Ventricular Septal Defect Closure Devices, Left Atrial Appendage Closure Devices), Technology (Self-Expandable Valve Technologies, Balloon-Expandable Valve Technologies, Transcatheter Mitral Annuloplasty Technologies, Transcatheter Chordal Repair Technologies, Percutaneous Septal Occlusion Technologies, Percutaneous Left Atrial Appendage Occlusion Technologies, Surgical Valve Repair & Replacement Technologies), Application (Aortic Stenosis Treatment, Mitral Regurgitation Treatment, Mitral Stenosis Treatment, Tricuspid Regurgitation Treatment, Patent Foramen Ovale Repair, Atrial Septal Defect Repair, Ventricular Septal Defect Repair, Left Atrial Appendage Stroke Prevention), End-User (Hospitals, Specialty Cardiology Clinics, Ambulatory Surgical Centers, Academic & Research Institutes), Component (Implantable Valves, Implantable Occluder Devices, Transcatheter Delivery Systems, Accessory Devices), and Material Type (Nitinol, Polymers & Fabrics, Bioprosthetic Tissue, Cobalt Chromium Alloy, Stainless Steel, Platinum Iridium Alloy, Other Alloys & Composites). Key regions served include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Leading companies include Terumo Corporation, LivaNova, MicroPort Scientific, Getinge, Meril Life Sciences, Venus Medtech, Lepu Medical, JenaValve Technology, Sahajanand Medical Technologies (SMT), Occlutech, HighLife Medical, and New Valve Technology (NVT). The full report covers market sizing and forecast from 2025 to 2035, along with detailed analysis of all segments and regions.
Market Definition & Overview
The Structural Heart Devices Market encompasses a range of specialized medical devices designed for the minimally invasive treatment and repair of structural heart diseases, including congenital defects, valvular disorders, and other anatomical abnormalities of the heart. This market primarily focuses on percutaneous and transcatheter-based interventions, offering alternatives to traditional open-heart surgery. It includes devices for valve repair and replacement, septal defect closure, and left atrial appendage occlusion, aiming to improve cardiac function and patient outcomes by addressing structural imperfections within the heart chambers, walls, and valves.
Scope
- Global market coverage across all major regions
- Analysis of various structural heart device product segments
- Market sizing and forecast from 2025 to 2035
Inclusions
- Transcatheter Aortic Valve Replacement (TAVR) devices
- Transcatheter Mitral Valve Repair/Replacement (TMVR) devices
- Left Atrial Appendage (LAA) closure devices
- Septal defect closure devices (ASD, PFO, VSD)
- Tricuspid valve repair/replacement devices
- Annuloplasty rings and prosthetic heart valves for structural interventions
Exclusions
- Traditional open-heart surgical instruments and procedures
- Pharmacological treatments for structural heart diseases
- Coronary artery disease (CAD) devices like coronary stents
- Electrophysiology devices such as pacemakers and defibrillators
- General cardiology diagnostic imaging equipment
Market Size Forecast
Executive Summary
• The Structural Heart Devices market is valued at $5.0 Bn in 2025 and is forecast to reach $8.7 Bn by 2035, reflecting a robust CAGR of 5.7% as demand accelerates across every major segment and region over the ten-year outlook.
• Transcatheter Aortic Valve Replacement Devices leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Technological advancements in transcatheter therapies, particularly TAVR and TMVR, are significantly expanding treatable patient populations across all major regions, intensifying strategic focus on broader indication approvals and procedural efficiency.
• The competitive landscape is rapidly evolving through targeted M&A activities, as leading device manufacturers strategically integrate innovative start-ups to fortify their portfolios and gain market share in high-growth segments.
• Emerging economies, especially in APAC, represent critical growth frontiers, necessitating localized market access strategies, physician training, and cost-effective solutions to overcome reimbursement hurdles and expand treatment availability.
• Evolving clinical guidelines and favorable regulatory pathways are pivotal in expanding treatment eligibility, encouraging continued investment in robust clinical evidence generation to support next-generation device adoption across demographics.
• Beyond TAVR's mature growth, the emerging TMVR and tricuspid repair segments are poised for significant expansion, attracting substantial investment and fostering a new wave of disruptive device innovation for underserved patient groups.
• Strategic consolidation efforts among key players are reshaping market dynamics, prioritizing comprehensive structural heart portfolios to optimize hospital partnerships and secure long-term global market leadership positions.
Key Market Takeaways
Critical findings and data points from this market research study.
Market Valuation
The Structural Heart Devices Market was valued at a significant $5.0 billion in the base year, establishing its current market scale.
Projected Growth
The market is projected to expand substantially, reaching $8.7 billion by the forecast year, indicating strong future demand.
Healthy CAGR
This growth trajectory translates to a Compound Annual Growth Rate (CAGR) of 5.7%, underscoring a steady and promising market expansion.
Leading Segment
The Transcatheter Aortic Valve Replacement (TAVR) segment is anticipated to continue its dominance, driving significant market revenue due to its growing adoption.
Regional Leadership
North America is expected to maintain its leadership in market share, propelled by advanced healthcare infrastructure and high adoption rates of novel devices.
Innovation Trend
A key market trend is the continuous innovation in minimally invasive procedures and next-generation device development, enhancing treatment efficacy and patient outcomes.
Market Dynamics
Market Trends
- Shift towards minimally invasive structural heart procedures continues.
- Rapid technological advancements improve device efficacy and safety.
- Increasing adoption of transcatheter mitral and tricuspid valve therapies.
- Real-world evidence and data analytics are enhancing clinical outcomes.
Growth Drivers
- Growing global prevalence of structural heart diseases fuels demand.
- Aging population significantly increases patient pool for interventions.
- Improved diagnostic techniques lead to earlier disease detection.
- Favorable reimbursement policies encourage market expansion and access.
Restraints
- High device and procedure costs limit market accessibility.
- Stringent regulatory processes delay market entry for innovations.
- Potential for procedural complications remains a key challenge.
- Limited access to specialized centers and skilled professionals constrains growth.
Opportunities
- Significant growth potential in developing and emerging economies.
- Innovation in novel devices for complex structural heart conditions.
- Expansion into pediatric structural heart interventions offers new niche.
- Telemedicine and remote monitoring enhance post-procedure patient care.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Transcatheter Aortic Valve Replacement DevicesTranscatheter Mitral Valve Repair DevicesTranscatheter Mitral Valve Replacement DevicesTranscatheter Tricuspid Valve Repair & Replacement DevicesPatent Foramen Ovale Closure DevicesAtrial Septal Defect Closure DevicesVentricular Septal Defect Closure DevicesLeft Atrial Appendage Closure Devices |
| By Technology | Self-Expandable Valve TechnologiesBalloon-Expandable Valve TechnologiesTranscatheter Mitral Annuloplasty TechnologiesTranscatheter Chordal Repair TechnologiesPercutaneous Septal Occlusion TechnologiesPercutaneous Left Atrial Appendage Occlusion TechnologiesSurgical Valve Repair & Replacement Technologies |
| By Application | Aortic Stenosis TreatmentMitral Regurgitation TreatmentMitral Stenosis TreatmentTricuspid Regurgitation TreatmentPatent Foramen Ovale RepairAtrial Septal Defect RepairVentricular Septal Defect RepairLeft Atrial Appendage Stroke Prevention |
| By End-User | HospitalsSpecialty Cardiology ClinicsAmbulatory Surgical CentersAcademic & Research Institutes |
| By Component | Implantable ValvesImplantable Occluder DevicesTranscatheter Delivery SystemsAccessory Devices |
| By Material Type | NitinolPolymers & FabricsBioprosthetic TissueCobalt Chromium AlloyStainless SteelPlatinum Iridium AlloyOther Alloys & Composites |
Regional Analysis
- North America dominates the structural heart devices market due to high prevalence of cardiovascular diseases, robust healthcare infrastructure, and strong reimbursement policies. Its focus on technological advancements and early adoption of innovative treatments further solidifies its leading position in this medical device sector.
- Asia Pacific is the fastest-growing region, driven by its large and aging population, increasing prevalence of heart diseases, and improving healthcare infrastructure. Rising disposable incomes, growing medical tourism, and government investments in healthcare further fuel market expansion and adoption of advanced devices.
- In Europe, a noteworthy trend is the increasing adoption of transcatheter mitral valve repair (TMVR) and replacement (TMVR) procedures, driven by an aging population and favorable clinical outcomes. There's also a growing focus on cost-effectiveness and value-based care within the structural heart device market.
| Asia PacificXX.X% | North AmericaXX.X% | EuropeXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A highly mature market with advanced healthcare infrastructure, strong reimbursement policies, and high adoption rates of innovative structural heart devices, supported by a significant aging demographic.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Experiencing accelerating growth due to increasing healthcare investments, rising awareness of cardiovascular diseases, and expanding access to advanced medical treatments in major economies like Brazil and Mexico.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Characterized by an aging population and well-established healthcare systems, this region maintains a substantial market share, though growth may be moderate due to market maturity and varying national healthcare policies.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region is poised for significant growth, driven by a large and aging population, increasing healthcare expenditure, and improving medical infrastructure, particularly in China and India.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Growth is propelled by rising healthcare expenditure in the Middle East and improving economic conditions in certain African nations, alongside an increasing prevalence of cardiovascular conditions, despite significant regional disparities.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. remains the largest and most mature market for structural heart devices, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and continuous innovation in treatment technologies. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | As the largest economy in South America, Brazil shows significant potential due to its large population, increasing incidence of cardiovascular diseases, and expanding public and private healthcare investments. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany is a leading European market, propelled by its robust healthcare system, high research and development spending, and widespread adoption of cutting-edge structural heart repair and replacement technologies. |
| 4 | China | US$ XX.X Mn | XX.X% | China is a rapidly expanding market for structural heart devices, driven by its massive patient population, increasing healthcare spending, and significant investments in local manufacturing and technology adoption. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Saudi Arabia is a key market in the region, driven by significant government investment in healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a growing medical tourism sector. |
Countries Covered (25)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, France, United Kingdom, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Malaysia, Rest of Asia Pacific, Saudi Arabia, South Africa, United Arab Emirates, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Terumo Corporation | XX.X% | Focus on providing comprehensive solutions for complex cardiovascular interventions, including structural heart, leveraging advanced interventional tools. | — | — | Aquacore TAVI SystemHeartrail Guiding CathetersFineCross MG Micro-Catheter |
| 2 | LivaNova | XX.X% | Innovate in less invasive cardiac surgery solutions and neuromodulation, focusing on high-growth segments after portfolio streamlining. | — | — | Perceval Plus Sutureless Aortic Heart ValveSorin Bicarbon Aortic ValveMemphis Perfusion System |
| 3 | MicroPort Scientific | XX.X% | Drive innovation in high-growth medical device markets, particularly structural heart, with a strong focus on the Chinese market and international expansion. | — | — | VitaFlow Liberty TAVI SystemReAortic Aortic ValveFirehawk Coronary Stent |
| 4 | Getinge | XX.X% | Provide high-quality medical technology and solutions primarily for surgery, intensive care, and sterile reprocessing, supporting critical care environments. | — | — | Cardiohelp SystemMaquet Datascope IABPJostra HL 20 Heart-Lung Machine |
| 5 | Meril Life Sciences | XX.X% | Develop affordable, high-quality medical devices for cardiovascular care, focusing on emerging markets and expanding global presence. | — | — | MyVal TAVI SystemMeRes100 Sirolimus Eluting Coronary StentMilo AF Ablation Catheter |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Terumo Corporation, LivaNova, MicroPort Scientific, Getinge, Meril Life Sciences, Venus Medtech, Lepu Medical, JenaValve Technology, Sahajanand Medical Technologies (SMT), Occlutech, HighLife Medical, New Valve Technology (NVT), Anteris Technologies, NeoChord, Cardiac Dimensions, Braile Biomedica, Beijing Balance Medical Technology, Valgen Medtech, V-Wave Ltd, 4C Medical
The global Structural Heart Devices market features a competitive landscape led by Terumo Corporation, LivaNova, MicroPort Scientific, Getinge, Meril Life Sciences, and Venus Medtech, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Terumo Corporation
LivaNova
MicroPort Scientific
Getinge
Meril Life Sciences
Venus Medtech
Lepu Medical
JenaValve Technology
Sahajanand Medical Technologies (SMT)
Occlutech
HighLife Medical
New Valve Technology (NVT)
Anteris Technologies
NeoChord
Cardiac Dimensions
Braile Biomedica
Beijing Balance Medical Technology
Valgen Medtech
V-Wave Ltd
4C Medical
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Medtronic Launches Latest Generation Self-Expanding TAVR System
Medtronic announced the global launch of its newest transcatheter aortic valve replacement (TAVR) system, featuring enhanced design for improved conformability and expanded size range. This launch aims to reinforce its competitive position in the rapidly evolving TAVR market.
Abbott Acquires Innovative Tricuspid Valve Repair Specialist
Abbott announced the acquisition of ValuFix Medical, a privately held company developing a novel transcatheter tricuspid valve repair system. This strategic move strengthens Abbott's leadership in structural heart interventions, particularly in addressing unmet needs in tricuspid valve disease.
Edwards SAPIEN X4 TAVR System Receives CE Mark and European Launch
Edwards Lifesciences announced CE Mark approval and immediate European launch of its SAPIEN X4 transcatheter aortic valve replacement system, designed for even lower profile delivery and improved patient outcomes. This milestone solidifies Edwards' continued innovation and market leadership in the European TAVR landscape.
Strategic Investment Fuels Development of Novel Transcatheter Mitral Repair Device
A consortium led by XYZ Ventures and including strategic investment from a leading structural heart device manufacturer announced a significant funding round for CardioInnovate Inc., a startup developing a groundbreaking transcatheter mitral valve repair technology. This investment will accelerate clinical trials and market access for the innovative device.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $5.0 Bn |
| Market Size (Forecast) | $8.7 Bn |
| CAGR | 5.7% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 25 Countries |
| Segments Covered | 6 Segments, 38 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Structural Heart Devices Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The Structural Heart Devices market is estimated at $5.0 Bn in 2025. It is forecast to reach $8.7 Bn in 2035, indicating significant expansion over the decade.
The Structural Heart Devices market is forecast to grow at a CAGR of 5.7% from 2025 to 2035. This growth reflects increasing demand for minimally invasive cardiac interventions.
The main segments include devices for Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair, and Left Atrial Appendage Closure. Other segments cover various technologies, applications, end-users, components, and material types.
Leading companies in this market include Terumo Corporation, LivaNova, MicroPort Scientific, Getinge, Meril Life Sciences, Venus Medtech, Lepu Medical, JenaValve Technology, Sahajanand Medical Technologies (SMT), Occlutech, HighLife Medical, and New Valve Technology (NVT).
The report provides global market coverage across all major regions. It includes analysis of various structural heart device product segments, along with market sizing and forecasts from 2025 to 2035.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Heart Valve Devices Market
$5.3 Bn in 2025 · 6.0% CAGR
Structural Heart Imaging Market
$1.1 Bn in 2025 · 7.2% CAGR
Audiology Devices Market
$12.9 Bn in 2025 · 5.7% CAGR
Autotransfusion Devices Market
$310.0 Mn in 2025 · 5.1% CAGR
Cardiac Monitoring Devices Market
$6.4 Bn in 2025 · 6.0% CAGR
Connected Medical Devices Market
$28.0 Bn in 2025 · 12.5% CAGR
Endoluminal Suturing Devices Market
$500.0 Mn in 2025 · 12.3% CAGR
Peripheral Vascular Devices Market
$4.8 Bn in 2025 · 5.9% CAGR